The cephalosporin antibiotics

Primary Care Update for Ob/Gyns

Volumn 4, Issue 5, 1997, Pages 168-174

  Christian, Stefanie S ^a   Christian, Jeffrey S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFACLOR; CEFADROXIL; CEFALEXIN; CEFALOTIN; CEFAMANDOLE NAFATE; CEFAPIRIN; CEFAZOLIN; CEFEPIME; CEFIXIME; CEFONICID; CEFOPERAZONE; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFPODOXIME PROXETIL; CEFPROZIL; CEFRADINE; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; LORACARBEF; PENICILLIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BLOOD TOXICITY; DRUG BLOOD LEVEL; DRUG COST; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG PROTEIN BINDING; GASTROINTESTINAL TOXICITY; GONORRHEA; HUMAN; INFECTION PREVENTION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PELVIC INFLAMMATORY DISEASE; PENICILLIN ALLERGY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; TREATMENT INDICATION; URINARY TRACT INFECTION;

EID: 0030865999     PISSN: 1068607X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1068-607X(97)81469-2     Document Type: Article

References (17)

1. Goldberg DM. The cephalosporins. Med Clin North Am 1987;71:1113-33.
2. American Medical Association. Drug Evaluation: cephalosporins and related agents. Chicago (IL): AMA, 1992.
3. Livermore DM. Mechanisms of resistance to cephalosporin antibiotics. Drugs 1987;34 (suppl 2):64.
4. Donowitz GR. Third generation cephalosporins. Infect Dis Clin North Am 1989;3:595.
5. Cunha BA, Gill MV. Cefepime. Med Clin North Am 1995;79:721-32.
6. Graham JM, Oshiro BT, Blanco JD. Limited-spectrum (first generation) cephalosporins. Ob Gyn Clin North Am 1992;19:449-59.
7. Eriksen NL, Blanco JD. Extended-spectrum (second-and third-generation) cephalosporins. Ob Gyn Clin North Am 1992;19:461-74.
8. Nightingale CH, Greene DS, Quintiliani R. Pharmacokinetics and clinical use of cephalosporin antibiotics. J Pharm Sci 1975;64:1899-1927.
9. Rodman DP, McKnight JT, Anderson RL. A critical review of the new oral cephalosporins, considerations and place in therapy. Arch Fam Med 1994;3:975-80.
10. Andriole VT. Pharmacokinetics of cephalosporins in patients with renal failure or reduced renal function. J Infect Dis 1978;137 (suppl): S88.
11. Duff P. Prophylactic antibiotics for cesarean delivery: a simple cost-effective strategy for prevention of postoperative morbidity. Am J Obstet Gynecol 1987;157:794-8.
12. Soper DE, Yarwood RL. Single-dose antibiotic prophylaxis in women undergoing vaginal hysterectomy. Obstet Gynecol 1987;69:879-82.
13. United States Department of Health and Human Services. 1993 U.S. DHHS sexually transmitted diseases treatment guidelines. MMWR 1993;42.
14. Brogan, JC. Sorting out the cephalosporins. Postgrad Med 1992;91: 301-15.
15. Sanchez-Ramos L, McAlpine KJ, Adair CD, et al. Pyelonephritis in pregnancy: once-a-day ceftriaxone versus multiple doses of cefazolin. Am J Obstet Gynecol 1995;172:129-33.
16. Janknetgt R, van der Meer JWM. Antimicrobial practice: sequential therapy with intravenous and oral cephalosporins. J Antimicrob Chemother 1994;33:169-77.
17. Anne S, Reisman RE. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol 1995;75:167-70.